shared care for Attention Deficit Hyperactivity Disorder (ADHD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Attention Deficit Hyperactivity Disorder (ADHD)+1 More
Shared Care - Other
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

Due to the shortage of child psychiatrists and the high prevalence of child mental health disorder, pediatricians and other pediatric primary care providers often assume responsibility for the management of various psychiatric disorders, including ADHD, Attention Deficit Hyperactivity Disorder. However, pediatricians have not been well-trained during residency to deal with the complexities of ADHD management. In addition, the system of care under which pediatricians practice do not afford the time availability that is required to properly manage a child with ADHD. On the other hand, if a pediatrician wishes to refer a patient to a child mental health specialist, many obstacles, including but not limited to stigma, insurance issues, and long waiting lists, often interfere with the patient actually receiving services for his/her ADHD. This research project seeks to examine an innovative model of care in which a child psychologist is located on the premises of a pediatric office and is available to share the care of patients with the pediatrician in order to address ADHD. We hypothesize that parents as well as pediatricians will be more satisfied with this model of care and that patients will ultimately have better outcomes. The beginning of our pilot has shown under-identification to be a barrier to care as well, and thus we propose to implement a quality improvement initiative to screen children for psychosocial issues as well. As we have had trouble with recruitment and unfortunately have had more children randomized to TAU than shared care, we propose in December 2007 a phase 2 of our study where all subjects, instead of randomization, are entered into shared care.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: six months

six months
2. Patients whose providers are offered to receive the aid of the co-located psychologists will be more likely to be co-managed by the pediatrician than referred out to the community.
A higher proportion of patients treated by the pediatric providers and psychologists than those in usual care receive doses of medication that are consistent with AAP (American Academy of Pediatrics) recommendations
Co-located services will increase the number of ADHD patients accessing specialized mental health treatment services
Parents will be more satisfied with care in the shared care model than in usual care

Trial Safety

Trial Design

2 Treatment Groups

TAU
1 of 2
shared care
1 of 2
Active Control
Experimental Treatment

140 Total Participants · 2 Treatment Groups

Primary Treatment: shared care · No Placebo Group · N/A

shared care
Other
Experimental Group · 1 Intervention: Shared Care · Intervention Types: Other
TAUNoIntervention Group · 1 Intervention: TAU · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: six months

Who is running the clinical trial?

New York State Psychiatric InstituteOTHER
455 Previous Clinical Trials
148,593 Total Patients Enrolled
11 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
610 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Columbia UniversityOTHER
1,282 Previous Clinical Trials
1,613,100 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
61 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Weill Medical College of Cornell UniversityLead Sponsor
983 Previous Clinical Trials
1,337,922 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
106 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
National Institute of Mental Health (NIMH)NIH
2,522 Previous Clinical Trials
1,814,643 Total Patients Enrolled
90 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
20,005 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Research Foundation for Mental Hygiene, Inc.OTHER
58 Previous Clinical Trials
16,442 Total Patients Enrolled
Daniel Hyman, MDPrincipal InvestigatorNew York Presbyterian Hospital
Rachel Zuckerbrot, MDPrincipal InvestigatorColumbia University/New York State Psychiatric Institute
Mark Olfson, MDPrincipal InvestigatorColumbia University/New York State Psychiatric Institute

Eligibility Criteria

Age < 18 · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 4th, 2021

Last Reviewed: October 18th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.